Journal Articles
Oncoscience
Year : 2018
CHLOE FERAL : Connect in order to contact the contributor
https://hal.univ-cotedazur.fr/hal-02526788
Submitted on : Tuesday, March 31, 2020-5:47:16 PM
Last modification on : Wednesday, September 6, 2023-10:42:11 AM
Dates and versions
Identifiers
- HAL Id : hal-02526788 , version 1
- DOI : 10.18632/oncoscience.416
- PUBMEDCENTRAL : PMC6049313
Cite
Laetitia Seguin, Chloe C. Feral. Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer. Oncoscience, 2018, pp.124. ⟨10.18632/oncoscience.416⟩. ⟨hal-02526788⟩
Collections
29
View
0
Download